upper endoscopy.
Conditions
Interventions
Intervention 1: The first intervention group: after receiving 0.05 mg / kg Midazolam and 40 mg / min Propofol maintenance, we give the first group 1 ug / kg Fentanyl (from Abu Reihan company) with the
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Patients undergoing upper endoscopy Patients aged 20 to 40 years
Exclusion criteria
Exclusion criteria: Addiction High blood pressure Hyperlipidemia Underlying disease, including thyroid disease, etc. Patients with G6PD disorder Myasthenia gravis methemoglobinemia Heart block Wolff-Parkinson-White syndrome Adams-Stokes syndrome Low blood potassium levels
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Checking of blood pressure once before drug administration and once after drug injection before endoscopy and then every 5 minutes until completion of work. Method of measurement: Patient monitoring system.;Heart rate. Timepoint: Checking of heart rate once before drug administration and once after drug injection before endoscopy and then every 5 minutes until completion of work. Method of measurement: Patient monitoring system.;Arterial blood oxygen saturation. Timepoint: Checking of arterial blood oxygen saturation once before drug administration and once after drug injection before endoscopy and then every 5 minutes until completion of work. Method of measurement: Patient monitoring system.;Respiratory rate. Timepoint: Checking of respiratory rate saturation once before drug administration and once after drug injection before endoscopy and then every 5 minutes until completion of work. Method of measurement: Patient monitoring system.;Gag reflex. Timepoint: During upper endoscopy. Method of measurement: Doctor checkup. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Ahmadinejad
Kerman University of Medical Sciences
Outcome results
None listed